The Valley Desk

NCT06991556 · Interventional trial

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Overall registry status Active not recruiting

Phase 2

Conditions Metastatic Hormone-sensitive Prostate Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov